Qube Research & Technologies (QRT)’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-117,587	Closed	-$784K	–	4877
2023 Q3	$784K	Buy	117,587 +90,230	+330%	+$750K	﹤0.01%	1844
2023 Q2	$248K	Buy	+27,357	New	+$241K	﹤0.01%	1717
2022 Q1	–	Sell	-41,412	Closed	-$232K	–	3165
2021 Q4	$232K	Buy	+41,412	New	+$311K	﹤0.01%	1915

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Qube Research & Technologies (QRT)'s PNT Position: Q4 2023 in Review

Qube Research & Technologies (QRT) sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 117,587 shares — an estimated $784K sold.

Qube Research & Technologies (QRT) first reported a position in PNT in Q4 2021 and held it in 3 quarters. The position peaked at $784K in Q3 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Qube Research & Technologies (QRT) reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 117,587 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $784K.
Qube Research & Technologies (QRT) first reported a position in POINT Biopharma Global Inc. Common Stock in Q4 2021 and held it in 3 quarters.
Qube Research & Technologies (QRT)'s POINT Biopharma Global Inc. Common Stock position peaked at $784K in Q3 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2023, filed 13 Feb 2024.